GlaxoSmithKline plc (LSE:GSK) may continue with its plans to acquire a majority stake in its Nigerian unit after suspending the plan four months ago. Chidi Okoro, Chief Executive Officer of GlaxoSmithKline Consumer Nigeria Plc (NGSE:GLAXOSMITH), said that the plan by GSK to increase equity in its Nigerian unit was only suspended and will come up later when all parties involved reach an agreement. Chidi said, "Our focus is that if it has to be done, it's done right." GSK, in July 2013, proposed to raise its stake in the Nigerian business to 80% from 46.4%, in a transaction estimated at $98 million.